Onco-Nutrition and Supplements Market Size is expected to record a healthy CAGR between 2022 and 2028 driven by the rising need for proper nutrition for living well during and after cancer treatment. According to studies, proper nutrition is a vital factor in boosting immunity and not only helps in the prevention of cancer but also assists in enhancing the effectiveness of cancer treatment.
Therefore, numerous institutions are focused on the development of multidisciplinary team of experts that help in devising the pattern of administration, dosage, and the implications of the therapy on the overall well-being of the patient.
On the basis of cancer type, the head and neck cancer segment is anticipated to account for a considerable share in the onco-nutrition and supplements market through 2028 owing to the growing importance of nutrition for individuals diagnosed with the disease. According to statistics, an estimated 30% to 50% of head and neck cancer patients experience malnutrition prior to the beginning of the treatment. Growing demand for meeting nutritional requirements among those diagnosed with cancer for avoiding weight loss and catabolism owing to increased stress and hypermetabolism is expected to drive segmental expansion over the forecast period.
Based on end-use, the hospitals segment is set to depict commendable growth by 2028. This rise is attributed to the multitude of services provided by hospitals such as medical nutrition therapy, nutrition screening & assessment, chemo patients’ food safety counseling, as well as preoperative and post-operative patient counseling. Moreover, numerous healthcare establishments are also specialized in the provision of nutrition support to radiation patients, nutrition counseling for cancer survivors, therapeutic diet planning, and conducting classes and academic workshop on subjects associated with nutrition.
Considering the regional landscape, the North America onco-nutrition and supplements market share is estimated to showcase robust growth through 2028. This rise is attributed to the increasing regulatory intervention for ensuring the maintenance of safety standards. For instance, the American Cancer Society has formulated numerous standards and oncology nutrition guidelines for ensuring the safety of nutrition products.
Furthermore, various organizations provide quality testing, enabling products to show a seal of quality assurance provided they pass particular tests. The products are also tested for ensuring that the ingredients listed on the label are actually present in the product, further ensuring that it does not contain any harmful chemicals or contaminants.
Major companies in the onco-nutrition and supplements market comprise Danone, Abbott, B. Braun Melsungen AG, Global Health Products, Hormel Foods, Nestle S.A., and others. These players are focused on the launch of mergers, acquisitions, partnerships, collaborations, and the development of novel onco nutrition products for maintaining their position in the market.
For instance, in January 2021, Senda Biosciences inked a strategic partnership with Nestle Health Science for the development of novel nutritional therapies for an extensive range of metabolic conditions, including glycemia and obesity.
The COVID-19 pandemic has elevated the importance of nutritional oncology owing to the unprecedented pressure on health care systems. The maintenance of adequate nutrition helps in bolstering the immune systems of the patient and subsequently helps in fighting against infection from SARS-CoV-2 virus.
As per studies, the maintenance of adequate nutrition becomes more vital in cancer patients whose immunity is already compromised owing to cancer therapy. These factors are set to open opportunities for product development across the onco-nutrition and supplements sector during the pandemic period.
Market, by Cancer Type
The above information is provided for the following regions and countries: